Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
about
Utility of susceptibility-weighted imaging in Parkinson's disease and atypical Parkinsonian disordersOptimizing odor identification testing as quick and accurate diagnostic tool for Parkinson's diseaseBrain MR Contribution to the Differential Diagnosis of Parkinsonian Syndromes: An UpdateNeuroimaging in pre-motor Parkinson's diseaseMeta-analysis of dorsolateral nigral hyperintensity on magnetic resonance imaging as a marker for Parkinson's disease.Efficient imaging of midbrain nuclei using inverse double-echo steady-state acquisitionThe role of high-field magnetic resonance imaging in parkinsonian disorders: Pushing the boundaries forward.Specificity and sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy.Region-Specific Iron Measured by MRI as a Biomarker for Parkinson's Disease.Neuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseThe Neuromelanin-related T2* Contrast in Postmortem Human Substantia Nigra with 7T MRIT2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson's Disease.9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease.The Concept of Prodromal Parkinson's Disease.Imaging synucleinopathies.Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).Magnetic resonance imaging for the diagnosis of Parkinson's disease.Ultra high-field SWI of the substantia nigra at 7T: reliability and consistency of the swallow-tail sign.Nigrosome 1 visibility at susceptibility weighted 7T MRI-A dependable diagnostic marker for Parkinson's disease or merely an inconsistent, age-dependent imaging finding?Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson's disease).Differential involvement of nigral subregions in idiopathic parkinson's disease.Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.Loss of dorsolateral nigral hyperintensity on 3.0 tesla susceptibility-weighted imaging in idiopathic rapid eye movement sleep behavior disorder.Nigral involvement in atypical parkinsonisms: evidence from a pilot study with ultra-high field MRI.Diagnosis of Early-Stage Idiopathic Parkinson's Disease Using High-Resolution Quantitative Susceptibility Mapping Combined with Histogram Analysis in the Substantia Nigra at 3 T.[Helpful instrumental examinations in idiopathic Parkinson's disease].Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson's disease.Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism
P2860
Q28066787-964CBC51-8115-4C6E-8100-C984D6AEFA70Q28071861-7F5EFD56-2839-4CBE-930B-2D6BD683C8DEQ28076062-7640FA68-48D4-4C6A-8102-531897A469D5Q33676222-F8A07B1D-FE5E-4A56-B56B-827E08125D09Q34550489-B0F2643E-5778-4DEB-A2E2-D52CFB43F645Q35788455-EA931FA6-375B-4D30-9182-59CBC762BCCEQ36332532-40345D5D-647D-4C25-BD04-771D9932FC3FQ36354065-69735C54-5548-4C45-9321-3FFE73D3F05DQ36374541-AF8A8E50-B221-4DCC-AAEC-67A8FDD9F836Q37192855-0894D720-CF70-480B-BD36-AB793A4904DBQ37232653-26AF4344-CBAE-4D3A-81E2-C85E45A2949FQ37351959-FC61704D-B3B1-4337-9F25-162A7BC5897BQ37485071-ACCE49E4-D1F5-4999-8741-4E5334C5B639Q38612230-A03D1A3A-E582-4CD3-90F8-89B923B1CF9FQ38734660-C35C4ECB-8EEE-42A4-B848-DE3A3122EE45Q38779931-A507A313-647B-4DC3-83A5-9E3BBB6B187EQ39176899-21E67E3C-4E2A-4E38-AE08-613615E28BE7Q39220904-D18B2A6A-F85F-4BB2-BFE4-0A71BD28AFD4Q42617557-43E6BFBA-9912-4200-AC79-ADBB0B75CFA5Q42706792-DF0AE44D-1D64-44E1-8FE0-E028634038B3Q43067221-A45B47D9-CA0D-4EDC-BE2A-F949021E0632Q47096030-B9E945F9-D205-4262-A655-AAD3E312456CQ47416232-99108007-EE05-47E5-8F89-7634B5FD4B16Q47653671-E0546EF9-3D59-429A-8D54-BD9388CEABF8Q47873853-32C61110-4891-45C8-8DA7-AD488385F240Q48859301-BF79CCC2-CBF2-4714-9DDD-2C38F87E6E8BQ50043640-F28B7EFB-27ED-4472-8630-4F27AEFDD9CFQ50240382-3A02B0CF-35F5-4AB3-AAE3-C54E8481EB40Q52592689-7E8221F9-D21A-40E2-A9F9-9E7F08FC26A2Q55312441-1796822D-E3D1-4D67-9DE0-8C4C726CAE10Q58576300-14BB1E48-B338-4FE6-A861-24492CA14899
P2860
Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@en
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@nl
type
label
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@en
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@nl
prefLabel
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@en
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dorsolateral nigral hyperinten ...... eurodegenerative Parkinsonism.
@en
P2093
Bernadette Pinter
Christian Kremser
Christoph Mueller
Christoph Scherfler
Eva Reiter
Michael Schocke
Regina Esterhammer
P2860
P304
P356
10.1002/MDS.26171
P407
P577
2015-03-15T00:00:00Z